Molecular control of aberrant adult-born granule cells in epilepsy

癫痫中异常成年颗粒细胞的分子控制

基本信息

  • 批准号:
    10737298
  • 负责人:
  • 金额:
    $ 42.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-08-01 至 2028-07-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: The latent period after a severe brain insult such as traumatic brain injury or status epilepticus, and before the onset of spontaneous recurrent seizures, is characterized by changes in adult hippocampal neurogenesis. Profound morphological changes, including hilar ectopic granule cells and abnormal dendritic development (e.g., hilar basal dendrites) is observed, therefore raising the question whether seizure- induced neurogenesis is epileptogenic. Our past work of ablating adult neurogenesis before or after acute seizures has shown a pro- epileptic role of new neurons, however existing ablation strategies in animal models have all suffered from an inability to decipher the mechanisms that promote aberrant adult-born granule cells (abGCs) because the cells are removed from the circuit. In this revised R01 application, we will capitalize on recently published work from our laboratory demonstrating that activity in immature abGCs regulates Ca2+ and gene expression which is necessary and sufficient for the production of aberrant abGCs and disruption of the hippocampal circuitry leading to epilepsy. We propose work to determine the mechanisms that promote aberrant neurogenesis, focusing on the genes and signaling pathways that drive aberrant abGCs as well as identifying the neuronal inputs to the aberrant abGCs. Because our past work has always been in the pilocarpine model of mesial temporal lobe epilepsy, we will expand these studies to address the role of aberrant abGCs in a non-status model, such as epilepsy that occurs after controlled cortical impact injury. In Aim 1, we will demonstrate that hM4Di-regulated gene expression in abGCs offers a new way to manipulate potential aberrant gene regulatory pathways and define the functional role of our top 2 candidate genes – Timp3 and Rrm2 - identified in RNA- sequencing analysis. In Aim 2, we will complement the work in Aim 1 using hM4Di in the pilocarpine model and identify the hM3Dq activated genes and neuronal inputs associated with aberrant abGCs in wild-type mice. In Aim 3, we will ablate or silence abGCs after controlled cortical impact injury and evaluate the impact on the development of chronic seizures. Together these studies are expected to provide a greater understanding of the mechanisms that promote aberrant abGC maturation, which may offer new strategies to specifically target abnormal new neurons while sparing healthy neurons. These studies would be broadly impactful in a variety of neurological disorders including epilepsy.
项目总结/文摘:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jenny Hsieh其他文献

Jenny Hsieh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jenny Hsieh', 18)}}的其他基金

ApoE4 in human cortical interneuron degeneration and network activity
ApoE4 在人类皮质中间神经元变性和网络活动中的作用
  • 批准号:
    9916999
  • 财政年份:
    2020
  • 资助金额:
    $ 42.45万
  • 项目类别:
Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline
针对异常的神经发生来预防癫痫和相关的认知能力下降
  • 批准号:
    9247257
  • 财政年份:
    2016
  • 资助金额:
    $ 42.45万
  • 项目类别:
Targeting aberrant neurogenesis to prevent epilepsy and associated cognitive decline
针对异常的神经发生来预防癫痫和相关的认知能力下降
  • 批准号:
    9127529
  • 财政年份:
    2016
  • 资助金额:
    $ 42.45万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8492002
  • 财政年份:
    2012
  • 资助金额:
    $ 42.45万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8851478
  • 财政年份:
    2012
  • 资助金额:
    $ 42.45万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8281205
  • 财政年份:
    2012
  • 资助金额:
    $ 42.45万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    9087084
  • 财政年份:
    2012
  • 资助金额:
    $ 42.45万
  • 项目类别:
Novel Mechanisms of Adult Neurogenesis in Physiological and Pathological Contexts
生理和病理背景下成人神经发生的新机制
  • 批准号:
    8719897
  • 财政年份:
    2012
  • 资助金额:
    $ 42.45万
  • 项目类别:
Genome-Wide Profiling of REST/NRSF Targets in Adult Neural Stem Cells
成体神经干细胞 REST/NRSF 靶标的全基因组分析
  • 批准号:
    8179569
  • 财政年份:
    2011
  • 资助金额:
    $ 42.45万
  • 项目类别:
Genome-Wide Profiling of REST/NRSF Targets in Adult Neural Stem Cells
成体神经干细胞 REST/NRSF 靶标的全基因组分析
  • 批准号:
    8274637
  • 财政年份:
    2011
  • 资助金额:
    $ 42.45万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 42.45万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了